.png){kind=icon}
.png){kind=icon}
Return
Genetically engineered transfusable platelets using mRNA lipid nanoparticles
.png){kind=icon}
OA
AI
DOI：10.1126/sciadv.adi0508.png)
.png){kind=icon}
.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
Platelet transfusions are essential for managing bleeding and hemostatic dysfunction and could be expanded as a cell therapy due to the multifunctional role of platelets in various diseases. Creating these cell therapies will require modifying transfusable donor platelets to express therapeutic proteins. However, there are currently no appropriate methods for genetically modifying platelets collected from blood donors. Here, we describe an approach using platelet-optimized lipid nanoparticles containing mRNA (mRNA-LNP) to enable exogenous protein expression in human and rat platelets. Within the library of mRNA-LNP tested, exogenous protein expression did not require nor correlate with platelet activation. Transfected platelets retained hemostatic function and accumulated in regions of vascular damage after transfusion into rats with hemorrhagic shock. We expect this technology will expand the therapeutic potential of platelets.
Keywords:
APHERESIS PLATELETS
HEMOSTATIC FUNCTION
CATIONIC LIPIDS
STORAGE
PLASMA
TRANSLATION
ACTIVATION
IPLAT1
CELLS
AI Summary
Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.
Journal
IF:
12.5
Papers:
2.0W
Citations:
18.1W
Organization
View more organizations